Clinical trial
A Combination Trial of Copaxone Plus Estriol in Relapsing Remitting Multiple Sclerosis (RRMS)
NCT00451204
Study timeline
Study start (unknown)2007-03-01Date precision: month
Registry last updated2016-06-16
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Relapsing Remitting Multiple Sclerosisunresolved
Interventions
Sponsors & collaborators
University of California, Los Angeleslead sponsor
Washington University School of Medicinecollaborator
University of Texas Southwestern Medical Centercollaborator
Ohio State Universitycollaborator
University of Chicagocollaborator
University of Utahcollaborator
Johns Hopkins Universitycollaborator
University of Kansas Medical Centercollaborator
University of Minnesotacollaborator
Mayo Cliniccollaborator
University of Colorado, Denvercollaborator
University of New Mexicocollaborator
University of Pennsylvaniacollaborator
Dartmouth-Hitchcock Medical Centercollaborator
National Multiple Sclerosis Societycollaborator
National Institutes of Health (NIH)collaborator
Mapped research locations
ChicagoIllinois, United States1Los AngelesCalifornia, United States1PhiladelphiaPennsylvania, United States1DallasTexas, United States1BaltimoreMaryland, United States1St LouisMissouri, United States1ColumbusOhio, United States1MinneapolisMinnesota, United States1AuroraColorado, United States1Salt Lake CityUtah, United States1AlbuquerqueNew Mexico, United States1Kansas CityKansas, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00451204 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.